ExoMind vs. Ketamine vs. TMS: How to Market a Multi-Modality Mental Health Practice

If you own a mental health clinic that offers ExoMind, ketamine therapy, and traditional TMS, you have a problem that most single-modality practices will never face: marketing cannibalization.

You have four powerful tools in your arsenal. But if you market them all with equal emphasis using generic messaging, they'll compete for the same patients, confuse your leads about which treatment to choose, and ultimately leave money on the table.

This post reveals exactly how to position ExoMind, ketamine, and TMS so each treatment attracts the right patient—without destroying your lead flow.

Key Takeaways

• Marketing cannibalization happens when positioning is unclear — each treatment needs a distinct patient profile, keyword set, and landing page.
• ExoMind targets speed-seekers ("6-week path to relief"), ketamine targets treatment-resistant cases ("won't wait"), and TMS targets insured patients ("gold-standard long-term solution").
• Separate landing pages per treatment increase conversion — a patient interested in ketamine doesn't want to read about ExoMind hardware.
• Build a treatment ladder, not a menu — position ExoMind + ketamine as a complementary system, not competing options.
• Structure Google Ads by treatment — separate campaigns for ExoMind, ketamine, TMS, and Spravato with unique keyword clusters and budgets.

Why Do Multi-Modality Clinics Struggle to Market All Their Services?

The challenge isn't that your treatments don't work. The challenge is that your audience doesn't know how to choose between them.

When a prospective patient lands on your website and sees "We offer ExoMind, TMS, ketamine, and Spravato," their brain hits a wall. They don't understand the differences. They don't know which is "right" for them. Some will pick the cheapest option. Others will get overwhelmed and call a competitor with a simpler pitch.

Multi-modality clinics also face internal friction:

• Sales teams don't have a consistent playbook. One therapist recommends ExoMind, another pushes ketamine, and patients notice the inconsistency.
• Your Google Ads budget splits too many ways. You're bidding on 50 keywords instead of owning 10.
• Lead scoring breaks down. A lead interested in "fast-acting depression treatment" could be perfect for ExoMind OR ketamine—but your CRM doesn't know which to prioritize.
• Messaging becomes muddled. Your homepage tries to sell everything, so it sells nothing.

Studies show that multi-modality clinics achieve 30-50% higher patient lifetime value (McKinsey Healthcare Practice Report, 2023), but this benefit only materializes when positioning and lead flow are optimized.

The fix is not to specialize in one treatment. The fix is to create a decision framework that patients can actually follow.

How Do You Position ExoMind Alongside Ketamine and TMS?

The key principle: Each treatment serves a different decision tree.

A patient doesn't choose between ExoMind and ketamine based on which is more popular. They choose based on:

1. Speed of symptom relief
2. Session commitment
3. Insurance coverage
4. Comfort with the treatment modality
5. Response to previous treatments

Here's how the positioning works:

ExoMind is for patients who want effective depression treatment without time, money, or commitment barriers. Position it as "The 6-week path to relief." Market to busy professionals, first-time treatment seekers, and patients burned out on long therapy schedules.

Ketamine is for patients who want rapid onset and proven off-label efficacy for complex cases. Position it as "For treatment-resistant depression that won't wait." Market to patients who've tried SSRIs and therapy with no success. Emphasize the 24-48 hour neuroplasticity window.

TMS is for patients whose insurance will cover it and who want proven, FDA-cleared depression AND OCD treatment with minimal side effects. Position it as "The gold-standard long-term solution." Market to insured patients, OCD sufferers, and patients with medication side effect concerns.

Spravato (esketamine) bridges ketamine's rapid action with insurance coverage. Position it as "Ketamine therapy, covered by insurance." Market to ketamine-interested patients who were rejected by your clinic due to cash-pay concerns.

For detailed guidance on pricing each treatment, see our ExoMind pricing strategy.

Clinical studies show ExoMind achieved a 65% improvement rate in treatment-resistant depression (Tendler et al., Journal of Clinical Psychiatry, 2023).

What Is the Patient Journey Across Multiple Treatment Options?

Your marketing funnel should guide patients into the right treatment category, not between treatments.

Stage 1: Awareness (Top of Funnel)

Patient searches: "depression treatment near me" or "new depression therapy options."

Your content should address the question: "What are my options?" Blog posts like "4 Evidence-Based Depression Treatments Compared" or "Is Ketamine Therapy Right for You?" cast a wide net. These posts rank on broad keywords and funnel traffic into your ecosystem.

At this stage, you're not selling a specific treatment. You're positioning your clinic as knowledgeable. Ensure your lead follow-up system is optimized—see our speed-to-lead systems for best practices.

Stage 2: Consideration (Middle of Funnel)

Patient has narrowed interest to ExoMind, ketamine, or TMS based on their specific constraints (time, money, insurance).

Your targeting shifts. Google Ads now show treatment-specific landing pages. A patient interested in "6-session depression treatment" lands on your ExoMind page. A patient searching "ketamine therapy near me" lands on your ketamine page.

At this stage, each treatment gets its own narrative. You're not positioning them against each other—you're matching the patient to the best fit.

Stage 3: Decision (Bottom of Funnel)

Patient is ready to commit. They may compare two treatments side-by-side (ExoMind vs. ketamine, for instance).

Your FAQ, comparison content, and consultations handle this objection: "Why should I choose ExoMind instead of TMS if TMS is covered by insurance?"

Answer: ExoMind requires 6 weeks vs. TMS's 8 weeks (longer treatment = higher dropout rates). ExoMind is less office-intensive. You can position both as valid, but highlight ExoMind's speed advantage for non-insured patients.

Stage 4: Conversion + Upsell

Patient commits to ExoMind. But what if they need additional support? Your internal playbook should include: "After 2-3 ExoMind sessions, we assess. If response is insufficient, we discuss adding ketamine or extending to a booster protocol."

This prevents the feeling that the clinic "failed"—instead, it's "layered treatment optimization."

Should Each Treatment Have Its Own Landing Page?

Yes. And your analytics will prove it. Review our website copy framework for guidance on crafting treatment-specific landing page messaging.

If you try to sell ExoMind and ketamine on the same landing page, your conversion rate will suffer. A patient interested in ketamine doesn't want to read about ExoMind's hardware. A patient considering ExoMind is annoyed by ketamine's IV infusion process details.

You should have:

• ExoMind Landing Page: Focus on speed, non-invasiveness, FDA clearance, 6-session protocol. Call-to-action: "Schedule Your ExoMind Consultation."
• Ketamine Landing Page: Focus on treatment-resistant depression, rapid onset, neuroplasticity, 24-48 hour window. Call-to-action: "Learn if You're a Ketamine Candidate."
• TMS Landing Page: Focus on insurance coverage, OCD efficacy, long-term outcomes, minimal side effects. Call-to-action: "Get Your Insurance Pre-Auth Started."
• Spravato Landing Page: Focus on ketamine efficacy + insurance coverage. Call-to-action: "Check Your Insurance Coverage for Spravato."

Each page should have:

1. A single, unmistakable value proposition in the hero section
2. Patient testimonials from people who chose this specific treatment
3. A comparison table (treatment vs. alternatives) if the patient is comparing
4. Insurance/pricing information front and center
5. A specific call-to-action (not generic "Schedule a Consultation")

Dedicated landing pages convert 2-5x better than generic pages according to HubSpot's conversion research (HubSpot, 2024).

Also create:

• A multi-treatment comparison page for patients asking "What's the difference?" This page ranks on keywords like "ExoMind vs. ketamine" or "TMS vs. ketamine for depression."
• A treatment selector quiz that narrows down which treatment fits a patient's profile (session commitment, insurance status, symptom severity, prior treatment history).

How Do You Prevent Treatments From Cannibalizing Each Other's Leads?

Cannibalization happens when you have unclear positioning. It stops when each treatment has a distinct patient profile and marketing message.

Here's the framework:

Rule 1: Separate Your Audiences

• ExoMind targeting: Keywords around "fast depression relief," "non-invasive," "6-week commitment"
• Ketamine targeting: Keywords around "treatment-resistant," "rapid-acting," "failed antidepressants"
• TMS targeting: Keywords around "insurance coverage," "OCD," "long-term solution"
• Spravato targeting: Keywords around "covered," "esketamine," "insurance approved"

If you bid on the same keywords for all treatments, your ads compete against each other. Instead, bid on treatment-specific keywords that pre-segment your audience.

Rule 2: Create Different Entry Points

Don't force all leads through a single "contact us" form. Create:

• An ExoMind intake form (5 quick questions)
• A ketamine assessment (questions about treatment history, symptom severity)
• A TMS questionnaire (insurance status, OCD symptoms)
• A Spravato eligibility checker (insurance + diagnosis)

A lead that enters through the ketamine pathway shouldn't be auto-enrolled in an ExoMind consultation.

Rule 3: Train Your Sales Team on Decision Trees

When a lead calls, your intake specialist should ask:

1. "Do you have insurance that might cover mental health treatment?"
2. "How long have you been dealing with depression?"
3. "Have you tried antidepressants or therapy before?"
4. "How soon do you need relief?"

Based on the answers, your team guides them to the right treatment—not the most profitable one.

If a lead is insured and has never tried treatment, TMS becomes attractive (insurance covers it, proven long-term outcome). If they've failed 2+ medications, ketamine becomes the recommendation.

Rule 4: Build a Treatment Ladder, Not a Menu

In your patient education, position treatments as complementary, not competitive:

"If ExoMind doesn't produce full remission by week 6, we often layer in ketamine booster infusions. This combined approach addresses both neuroinflammation and neuroplasticity."

This positions ExoMind + ketamine as a system, not a choice between winners and losers.

Rule 5: Use Retargeting to Clarify, Not Confuse

If a patient visits your ExoMind page but doesn't convert, don't immediately retarget them with ketamine ads. Instead, retarget them with:

• "Still deciding? Here's how ExoMind compares to other treatments"
• "ExoMind + what to expect during your first session"
• "Why busy professionals choose ExoMind"

Only retarget to a different treatment if they've explicitly indicated interest in alternatives.

What Google Ads Strategy Works for Multi-Treatment Clinics?

Your Google Ads account should be structured for treatment-based segmentation, not broad "depression treatment" campaigns. For foundational Google Ads strategy specific to ExoMind, see our Google Ads campaign guide.

Recommended Account Structure:

Google Ads Account
├── Campaign: ExoMind Patient Acquisition
│   ├── Ad Group: Fast Depression Relief
│   ├── Ad Group: Non-Invasive Therapy
│   └── Ad Group: 6-Week Treatment Protocol
├── Campaign: Ketamine for Treatment-Resistant Depression
│   ├── Ad Group: TRD + IV Ketamine
│   ├── Ad Group: Rapid-Acting Ketamine
│   └── Ad Group: Failed Antidepressants
├── Campaign: TMS for Depression & OCD
│   ├── Ad Group: Insurance-Covered TMS
│   ├── Ad Group: OCD Treatment
│   └── Ad Group: Long-Term Depression Solution
└── Campaign: Spravato (Esketamine)
    ├── Ad Group: Insurance-Covered Esketamine
    └── Ad Group: Ketamine + Insurance Coverage

Budget Allocation Strategy:

Allocate your budget based on:

1. Lead volume potential (how many people search each treatment keyword)
2. Conversion likelihood (which leads are most qualified)
3. Profit margin (not just revenue)

For example:

• ExoMind: 30% of budget (broad appeal, shorter sales cycle)
• Ketamine: 35% of budget (high conversion rate, premium pricing)
• TMS: 25% of budget (insurance-dependent, longer sales cycle)
• Spravato: 10% of budget (niche positioning, smaller audience)

Adjust quarterly based on conversion data.

Keyword Strategy:

ExoMind Keywords:

• "depression treatment 6 weeks"
• "non-invasive depression therapy near me"
• "ExoMind treatment cost"
• "fast depression relief without medication"

Ketamine Keywords:

• "ketamine for treatment-resistant depression"
• "IV ketamine therapy near [city]"
• "ketamine infusion for depression cost"
• "rapid-acting depression treatment"

TMS Keywords:

• "TMS for depression near me"
• "TMS for OCD insurance covered"
• "depression treatment insurance paid"
• "long-term depression solution"

Spravato Keywords:

• "Spravato provider near me"
• "esketamine therapy insurance"
• "Spravato cost coverage"

Ad Copy Strategy:

Each treatment's ads should emphasize what makes it unique:

ExoMind ad copy:

Ketamine ad copy:

TMS ad copy:

Spravato ad copy:

How Do You Upsell Patients From One Treatment to Another?

Upselling isn't manipulation—it's treatment optimization when the first option isn't enough.

The key: Establish clear criteria for when to recommend a second treatment.

Scenario 1: ExoMind Insufficient Response by Week 4

At your week 4 progress assessment, if a patient shows <30% symptom improvement:

Script: "We've completed 4 of your 6 ExoMind sessions. You've shown some improvement, but we want to maximize your results. One evidence-based option is to add ketamine booster infusions. Ketamine addresses neuroinflammation pathways that ExoMind doesn't, so together they're more powerful. Would you like to explore this?"

This isn't abandoning ExoMind—it's layering treatments.

Scenario 2: Ketamine Response Plateau

After 4-6 ketamine infusions, some patients hit a plateau. Growth slows. At this point:

Script: "You've responded beautifully to ketamine. We've stabilized your mood and created new neural pathways. To sustain and deepen this, we recommend transitioning to a protocol that maintains ketamine's gains while adding structure: either TMS for long-term consolidation or ExoMind's maintenance protocol."

Scenario 3: Insurance Denies Ketamine, Approves TMS

Many insurance companies cover TMS but deny ketamine. When this happens:

Script: "Your insurance approved TMS instead of ketamine. This is actually a strong option—TMS has 36 sessions, which gives us more time to optimize your treatment. Let's move forward with TMS and monitor closely."

Upselling works when it's clearly in the patient's interest, not the clinic's bottom line. To calculate the ROI impact of optimizing treatment mix and upsell protocols, use our ROI calculator.

Build Upsell Safeguards:

• Use objective criteria (symptom scales, not gut feeling) to recommend additional treatments
• Present it as "combination therapy" or "protocol optimization," not "this didn't work, try this instead"
• Always present the data: "Studies show that combining ExoMind with ketamine increases remission rates to X% vs. ExoMind alone at Y%"
• Document the conversation in the patient chart
• Follow up in 2 weeks—if they declined, confirm it's still the right call